Autoimmune bullous diseases associations

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 17-33

  Ljubojevic, Suzana ^a   Lipozenčić, Jasna ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AUROTHIOMALATE; BUCILLAMINE; CAPTOPRIL; CEPHALOSPORIN DERIVATIVE; CHLOROQUINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDROXYCHLOROQUINE; IMIQUIMOD; INTERFERON; INTERLEUKIN 1ALPHA; LISINOPRIL; MONTELUKAST; NIFEDIPINE; PENICILLAMINE; PENICILLIN DERIVATIVE; PHENOL DERIVATIVE; PIROXICAM; PYRAZOLONE DERIVATIVE; PYRITINOL; QUINOLONE DERIVATIVE; RAMIPRIL; RIFAMPICIN; THIAMAZOLE; THIOL DERIVATIVE; TIOPRONIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ARTICLE; AUTOIMMUNE BULLOUS DISEASE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CYTOKINE RELEASE; DERMATITIS HERPETIFORMIS; DISEASE ASSOCIATION; DRUG INDUCED PEMPHIGUS; EPIDERMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; IMMUNOPATHOLOGY; INTERCELLULAR IMMUNOGLOBULIN A DERMATOSIS; LINEAR IMMUNOGLOBULIN A DISEASE; MULTIPLE AUTOIMMUNE SYNDROME; PARANEOPLASTIC PEMPHIGUS; PEMPHIGOID; PEMPHIGOID GESTATIONIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS HERPETIFORMIS; PEMPHIGUS VEGETANS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CAUSALITY; COMORBIDITY; DERMATITIS HERPETIFORMIS; DERMIS; EPIDERMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; SKIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 83155184562     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.006     Document Type: Article

References (452)

1. Wojnarowska F Immunobullous diseases. Rook's textbook of dermatology 2010, Wiley-Blackwell, Singapore, 40.1.-40.62. T. Burns, C.N. Breathnach, C. Griffiths (Eds.).
2. Madan Mohan P., Ramesh T.C. Multiple autoimmune syndrome. Indian J Dermatol Venereol Leprol 2003, 298-299.
3. Gharia M.J., Fairley J.A., Lin M.S., Liu Z., Giudice G.J. Autoimmune diseases of the skin. Textbook of autoimmune diseases 2000, 409. Lippincott Williams & Wilkins, Philadelphia. R.G. Lahita, N. Chiorazzi, W.S. Reeves (Eds.).
4. Grandhe N.P., Dogra S., Kanwar A.J. Multiple autoimmune syndrome in a patient with pemphigus vulgaris. Acta Derm Venereol 2005, 85:91-92.
5. Meyer S., Kroiss M., Landthaler M., et al. Thymoma, myasthenia gravis, eruptions of pemphigus vulgaris and a favourable course of relapsing melanoma: an immunological puzzle. Br J Dermatol 2006, 155:638-640.
6. Rakocević-Stojanović V., Rakocević I., Perić S., et al. Intravenous immunoglobulin therapy in two patients with myasthenia gravis and pemphigus vulgaris. Acta Myol 2009, 28:101-102.
7. Kaufman A.J., Ahmed A.R., Kaplan R.P. Pemphigus, myasthenia gravis, and pregnancy. J Am Acad Dermatol 1988, 19:414-418.
8. Oka D., Shimoda A., Ueki H., et al. Coexistence of pemphigus vulgaris, myasthenia gravis and hepatocellular carcinoma. Dermatologica 1986, 172:177-178.
9. Shabbir S.G., Hassan M., Kazmi S.A., Suhail S. Myasthenia gravis and pemphigus vulgaris. J Pak Med Assoc 1984, 34:349-351.
10. Beutner E.H., Chorzelski T.P. Myasthenia and pemphigus. Neurology 1978, 28:857-858.
11. Norris D.L., Saywell M.S., Strutton G.M., et al. Pemphigus vulgaris associated with spindle cell thymoma. Australas J Dermatol 1993, 34:97-102.
12. Patten S.F., Dijkstra J.W. Associations of pemphigus and autoimmune disease with malignancy or thymoma. Int J Dermatol 1994, 33:836-842.
13. Gibson L.E., Muller S.A. Dermatologic disorders in patients with thymoma. Acta Derm Venereol 1987, 67:351-356.
14. van den Hoogenband H.M. An intrathoracic tumor and skin disorders (benign thymoma and pemphigus. Ned Tijdschr Geneeskd 1984, 128:1542.
15. Safai B., Gupta S., Good R.A. Pemphigus vulgaris associated with a syndrome of immunodeficiency and thymoma: a case report. Clin Exp Dermatol 1978, 129-134.
16. Imamura S., Tagami H., Ikai K., et al. Pemphigus, myasthenia gravis and thymoma. Nippon Hifuka Gakkai Zasshi 1977, 87:802-804.
17. Touraine R., Revuz J., de Prost Y., et al. Pemphigus, myasthenia and thymoma. Ann Med Interne (Paris) 1976, 127:923-927.
18. Tagami H., Imamura S., Noguchi S., et al. Coexistence of peculiar pemphigus, myasthenia gravis and malignant thymoma. Dermatologica 1976, 152:181-190.
19. Rosenow E.C., Hurley B.T. Disorders of the thymus. A review. Arch Intern Med 1984, 144:763-770.
20. Takeshita K., Amano M., Shimizu T., et al. Thymoma with pemphigus foliaceus. Intern Med 2000, 39:742-747.
21. Fuxiang G., Beutner E.H. Pemphigus erythematosus associated with thymoma: a case report. Cutis 1999, 64:179-182.
22. Cruz P.D., Coldiron B.M., Sontheimer R.D. Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma. J Am Acad Dermatol 1987, 16:472-480.
23. Barbosa E.R., Alchorne A.O., De Assis J.L., et al. Myasthenia gravis and pemphigus foliaceus. Med Cutan Ibero Lat Am 1982, 10:283-288.
24. Cooper A., Wells J.V. Pemphigus foliaceus, myasthenia gravis, and thymoma in a patient with serological evidence of SLE. Aust N Z J Med 1981, 11:277-280.
25. Hidalgo-Tenorio C., Sabio-Sánchez J.M., Tercedor-Sánchez J., et al. Pemphigus vulgaris and systemic lupus erythematosus in a 46-y-old man. Lupus 2001, 10:824-826.
26. Calebotta A., Cirocco A., Giansante E., et al. Systemic lupus erythematosus and pemphigus vulgaris: association or coincidence. Lupus 2004, 13:951-953.
27. Kuchabal D.S., Kuchabal S.D., Pandit A.M., et al. Pemphigus vulgaris associated with systemic lupus erythematosus. Int J Dermatol 1998, 37:636-638.
28. Fong P.H., Chan H.L. Systemic lupus erythematosus with pemphigus vulgaris. Arch Dermatol 1985, 121:26-27.
29. Somorin A.O., Agbakwu S.N., Nwaefuna A. Systemic lupus erythematosus and pemphigus vulgaris preceded by depressive psychosis. Cent Afr J Med 1981, 27:12-14.
30. Rossi A., Reszko A., Leach J., et al. Combined bullous pemphigoid and pemphigus vulgaris in an 18-year-old female. J Cutan Pathol 2010, 37:991-996.
31. Sami N., Ahmed A.R. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature. Dermatology 2001, 202:293-301.
32. Sami N., Bhol K.C., Beutner E.H., et al. Diagnostic features of pemphigus vulgaris in patients with bullous pemphigoid. Molecular analysis of autoantibody profile. Dermatology 2002, 204:108-117.
33. Ishii K., Amagai M., Ohata Y., et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000, 42:859-861.
34. Komai A., Amagai M., Ishii K., et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Br J Dermatol 2001, 144:1177-1182.
35. Tsuji Y., Kawashima T., Yokota K., et al. Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system. Arch Dermatol 2002, 138:95-96.
36. Feliciani C., Motta A., Castellaneta M., et al. Coexisting pemphigus vulgaris and pemphigus foliaceus in the same patient. Int J Dermatol 2005 Feb, 44:139-141.
37. Hodgson T.A., Fidler S.J., Speight P.M., et al. Oral pemphigus vulgaris associated with HIV infection. J Am Acad Dermatol 2003, 49:313-315.
38. Marfatia Y.S., Patel S., Makrandi S., et al. Human immunodeficiency virus and pemphigus vulgaris: an interesting association. Indian J Dermatol Venereol Leprol 2007, 73:354-355.
39. Splaver A., Silos S., Lowell B., et al. Case report: pemphigus vulgaris in a patient infected with HIV. AIDS Patient Care STDS 2000, 14:295-296.
40. Capizzi R., Marasca G., De Luca A., et al. Pemphigus vulgaris in a human-immunodeficiency-virus-infected patient. Dermatology 1998, 197:97-98.
41. Bull R.H., Fallowfield M.E., Marsden R.A. Autoimmune blistering diseases associated with HIV infection. Clin Exp Dermatol 1994, 19:47-50.
42. Memar O.M., Rady P.L., Goldblum R.M., et al. Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus. Arch Dermatol 1997, 133:1247-1251.
43. Memar O.M., Rady P.L., Goldblum R.M., et al. Human herpesvirus-8 DNA sequences in a patient with pemphigus vulgaris, but without HIV infection or Kaposi's sarcoma. J Invest Dermatol 1997, 108:118-119.
44. Tufano M.A., Baroni A., Buommino E., et al. Detection of virus DNA in peripheral blood mononuclear cells and skin lesions of patients with pemphigus by polymerase chain reaction. Br J Dermatol 1999, 141:1033-1039.
45. Valikhani M., Kavusi S., Chams-Davatchi C., et al. Pemphigus and associated environmental factors: a case-control study. Clin Exp Dermatol 2007, 32:256-260.
46. Brenner S., Tur E., Shapiro J., et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001, 40:562-569.
47. Brenner S., Srebrnik A., Goldberg I. Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols. J Cosmet Dermatol 2003, 2:161-165.
48. Brenner S., Ruocco V., Ruocco E., et al. A possible mechanism for phenol-induced pemphigus. Skinmed 2006, 5:25-26.
49. Brenner S., Wolf R. Possible nutritional factors in induced pemphigus. Dermatology 1994, 189:337-339.
50. Borrelli F., Capasso R., Izzo A.A. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007, 51:1386-1397.
51. Jappe U., Bonnekoh B., Hausen B.M., et al. Garlic-related dermatoses: case report and review of the literature. Am J Contact Dermat 1999, 10:37-39.
52. Ruocco V., Brenner S., Lombardi M.L. A case of diet-related pemphigus. Dermatology 1996, 192:373-374.
53. Stavropoulos P.G., Kostakis P.G., Papakonstantinou A.M., et al. Coexistence of psoriasis and pemphigus after enalapril intake. Dermatology 2003, 207:336-337.
54. Inamadar A.C. Association of alopecia areata, vitiligo and pemphigus vulgaris. Indian J Dermatol Venereol Leprol 1995, 61:157-158.
55. Jain R., Dogra S., Sandhu K., et al. Coexistence of vitiligo and pemphigus vulgaris in an indian patient. Pediatr Dermatol 2003, 20:369-370.
56. Pérez-Bernal A.M., Mazuecos J., Moreno J.C., et al. Coexistence of pemphigus vulgaris, lichen planus of the mouth mucosa and hepatitis B. Ann Dermatol Venereol 1989, 116:655-657.
57. Souissi A., Ben Tekaya N., Mourad M., et al. Darier's disease associated with pemphigus vulgaris: coexistence of two acantholytic mechanisms. Ann Dermatol Venereol 2006, 133:63-65.
58. Rae V., Gould E., Ibe M.J., et al. Coexistent pemphigus vulgaris and Paget's disease of the nipple. An immunohistochemical study. J Am Acad Dermatol 1987, 16:235-237.
59. Low G.J., Keeling J.H. Ionizing radiation-induced pemphigus. Case presentations and literature review. Arch Dermatol 1990, 126:1319-1323.
60. Laskaris G.C., Papavasiliou S.S., Bovopoulou O.D., et al. Association of oral pemphigus with chronic lymphocytic leukemia. Oral Surg Oral Med Oral Pathol 1980, 50:244-249.
61. Serwin AB, Bokiniec E, Chodynicka B. Pemphigus vegetans in a patient with lung cancer. Dermatol Online J 2005;11:13. Available at: Accessed December 26, 2010. http://dermatology.cdlib.org/111/case_reports/pemphigus/serwin.html.
62. Bastiaens M.T., Zwan N.V., Verschueren G.L., et al. Three cases of pemphigus vegetans: induction by enalapril-association with internal malignancy. Int J Dermatol 1994, 33:168-171.
63. Krain L.S., Bierman S.M. Pemphigus vulgaris and internal malignancy. Cancer 1974, 33:1091-1099.
64. Torres T., Ferreira M., Sanches M., et al. Pemphigus vegetans in a patient with colonic cancer. Indian J Dermatol Venereol Leprol 2009, 75:603-605.
65. Koga C., Izu K., Kabashima K., et al. Pemphigus vegetans associated with gastric cancer. J Eur Acad Dermatol Venereol 2007, 21:1288-1289.
66. Lateef A., Packles M.R., White S.M., et al. Pemphigus vegetans in association with human immunodeficiency virus. Int J Dermatol 1999, 38:778-781.
67. Mahé A., Flageul B., Prost C., et al. Pemphigus vegetans in an HIV-1-infected man. Clin Exp Dermatol 1994, 19:447.
68. Jordon R.E. Pemphigus erythematosus. Arch Dermatol 1982, 118:742.
69. Ng P.P., Ng S.K., Chng H.H. Pemphigus foliaceus and oral lichen planus in a patient with systemic lupus erythematosus and thymoma. Clin Exp Dermatol 1998, 23:181-184.
70. Korman N.J., Stanley J.R., Woodley D.T. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Arch Dermatol 1991, 127:387-390.
71. Harrington C.I., Sneddon I.B. Coexistence of bullous pemphigoid and pemphigus foliaceus. Br J Dermatol 1979, 100:441-445.
72. Yokoo M., Oka D., Ueki H. Coexistence of psoriasis vulgaris and pemphigus foliaceus. Dermatologica 1989, 179:222-223.
73. Tomasini D., Cerri A., Cozzani E., et al. Development of pemphigus foliaceus in a patient with psoriasis: a simple coincidence?. Eur J Dermatol 1998, 8:56-59.
74. Perez G.L., Agger W.A., Abellera R.M., et al. Pemphigus foliaceus coexisting with IgA nephropathy in a patient with psoriasis vulgaris. Int J Dermatol 1995, 34:794-796.
75. Panzarella K., Camisa C. Coexistence of superficial pemphigus and psoriasis. Cutis 1996, 57:414-418.
76. Masmoudi A., Hadj Taieb H., Ben Ayed M., et al. Tunisian erythematosus pemphigus associated with psoriasis in two sisters. Ann Dermatol Venereol 2006, 133:184-185.
77. Levine L., Bernstein J.E., Soltani K., et al. Coexisting childhood pemphigus foliaceus and Graves' disease. Arch Dermatol 1982, 118:602-604.
78. Sarnoff D.S., DeFeo C.P. Coexistence of pemphigus foliaceus and mycosis fungoides. Arch Dermatol 1985, 121:669-672.
79. Cunha P.R., Focaccia R.R., Diaz L.A. Evolution of endemic pemphigus foliaceus (fogo selvagem) after HIV-1 infection. J Am Acad Dermatol 1995, 32:809-811.
80. Ambay A., Stratman E. Ionizing radiation-induced pemphigus foliaceus. J Am Acad Dermatol 2006, 54:251-252.
81. Cianchini G., Lembo L., Colonna L., et al. Pemphigus foliaceus induced by radiotherapy and responsive to dapsone. J Dermatolog Treat 2006, 17:244-246.
82. Ongenae K.C., Temmerman L.J., Vermander F., et al. Intercellular IgA dermatosis. Eur J Dermatol 1999, 9:85-94.
83. Wallach D. Intraepidermal IgA pustulosis. J Am Acad Dermatol 1992, 27:993-1000.
84. Takata M., Inaoki M., Shodo M., et al. Subcorneal pustular dermatosis associated with IgA myeloma and intraepidermal IgA deposits. Dermatology 1994, 189:111-114.
85. Burrows D., Bingham E.A. Subcorneal pustular dermatosis and IgA gammopathy. Br J Dermatol 1984, 111:91-93.
86. Todd D.J., Bingham E.A., Walsh M., et al. Subcorneal pustular dermatosis and IgA paraproteinemia: response to both etretinate and PUVA. Br J Dermatol 1991, 125:387-389.
87. Miyagawa S., Hashimoto T., Ohno H., et al. Atypical pemphigus associated with monoclonal IgA gammopathy. J Am Acad Dermatol 1995, 32:352-357.
88. Barnadas M.A., Nadal C., Verger G., et al. Intraepidermal IgA pustulosis with monoclonal IgA gammopathy in an HIV-infected patient. Dermatology 1997, 194:308-309.
89. Bernard P., Amici J.M., Bedane C., et al. Dermatose neutrophilique à IgA intra-épidermique associée à un myélome à IgA. Ann Dermatol Venreol 1990, 117:890-892.
90. Wallach D., Foldes C., Cottenot F. Pustulose sous-cornée, acantholyse superficielle et IgA monoclonale. Ann Dermatol Venereol 1982, 109:959-963.
91. Borradori L., Saada V., Rybojad M., et al. Intraepidermal neutrophilic IgA pustulosis and Crohn's disease. Br J Dermatol 1992, 126:383-386.
92. Miyakawa K., Miyamoto R., Baba S., et al. Vesiculopustular dermatosis with ulcerative colitis. Concomitant occurrence of circulating IgA anti-tercellular and anti-basement membrane zone antibodies. Eur J Dermatol 1995, 5:122-124.
93. Varigos G.A. Subcorneal pustulosis with IgA abnormalities in serum and small bowel mucosa: case report. Aust J Dermatol 1979, 20:75-77.
94. Wright S., Phillips T., Ryan J., et al. Intra-epidermal neutrophilic IgA dermatosis with colitis. Br J Dermatol 1989, 120:13-19.
95. Wallach D., Janssen F., Vignon-Pennamen M.D., et al. Atypical neutrophilic dermatosis with subcorneal IgA deposits. Arch Dermatol 1987, 123:790-795.
96. Yoshida Y., Okamoto H., Mizuno K., et al. Subcorneal pustular type of intraepidermal neutrophilic IgA dermatosis: a combined treatment with low-dose dapsone and high-dose nicotinamide. Eur J Dermatol 1996, 6:287-289.
97. Kishimoto K., Iwatsuki K., Akiba H., et al. Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs. Eur J Dermatol 2001, 11:41-44.
98. Myers S.A., Rico M.J. Intraepidermal neutrophilic IgA dermatosis in an HIV infected patient. J Am Acad Dermatol 1994, 31:501-504.
99. Muldrow M. Intraepidermal neutrophilic IgA dermatosis in a patient with advanced human immunodeficiency virus infection. Arch Dermatol 1997, 133:667-668.
100. Petropoulou H., Politis G., Panagakis P., et al. Immunoglobulin A pemphigus associated with immunoglobulin A gammopathy and lung cancer. J Dermatol 2008, 35:341-345.
101. Chorzelski T.P., Hashimoto T., Nishikawa T., et al. Unusual acantholytic bullous dermatosis associated with neoplasia and IgG and IgA antibodies against bovine desmocollins I and II. J Am Acad Dermatol 1994, 31:351-355.
102. Chan L.S. Pemphigus Herpetiformis. Emedicine Last updated April 9, 2010. Available at:, Accessed: December 26, 2010. http://emedicine.medscape.com/article/1064550-overview.
103. Sanchez-Palacios C., Chan L.S. Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment. J Cutan Pathol 2004, 31:346-349.
104. Morita E., Amagai M., Tanaka T., et al. A case of herpetiform pemphigus coexisting with psoriasis vulgaris. Br J Dermatol 1999, 141:754-755.
105. Kubota Y., Yoshino Y., Mizoguchi M. A case of herpetiform pemphigus associated with lung cancer. J Dermatol 1994, 21:609-611.
106. Palleschi G.M., Giomi B. Herpetiformis pemphigus and lung carcinoma: a case of paraneoplastic pemphigus. Acta Derm Venereol 2002, 82:304-305.
107. Marzano A.V., Tourlaki A., Cozzani E., et al. Pemphigus herpetiformis associated with prostate cancer. J Eur Acad Dermatol Venereol 2007, 21:696-698.
108. Marinović B., Basta-Juzbašić A., Bukvić-Mokos Z., et al. Coexistence of pemphigus herpetiformis and systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2003, 17:316-319.
109. Verdier-Sevrain S., Joly P., Thomine E., et al. Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectron microscopy and immunoblot analysis. Br J Dermatol 1994, 130:238-240.
110. Anhalt G.J., Nousari C.H. Paraneoplastic pemphigus. Fitzpatrick's dermatology in general medicine 2008, 468-474. Mc Graw Hill, New York. K. Wolff, L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Leffel (Eds.).
111. Anhalt G.J., Kim S.C., Stanley J.R., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
112. Anhalt G.J. Paraneoplastic pemphigus. The role of tumours and drugs. Br J Dermatol 2001, 144:1102-1104.
113. Sklavounou A., Laskaris G. Paraneoplastic pemphigus: a review. Oral Oncol 1998, 34:437-440.
114. Hertzberg M.S., Schifter M., Sullivan J., et al. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone. Am J Hematol 2000, 63:105-106.
115. Martinez De Pablo M.I., Iranzo P., Mascaro J.M., et al. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol 2005, 85:233-235.
116. Tilakaratne W., Dissanayake M. Paraneoplastic pemphigus: a case report and review of literature. Oral Dis 2005, 11:326-329.
117. Batista M.D., Takano D., Lopes R.D., et al. Paraneoplastic pemphigus associated with non-Hodgkin lymphoma. Dermatol Online J 2008, 14:11.
118. Marzano AV, Grammatica A, Cozzani E, et al. Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia. Br J Dermatol 2001, 145:127-131.
119. Rivollier C., Vaillant L., Machet M.C., et al. Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia. Ann Dermatol Venereol 2001, 128:644-648.
120. van Mook W.N.K., Fickers M.M., Theunissen P.H., et al. Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia. Ann Oncol 2001, 12:115-118.
121. Kop E.N., MacKenzie M.A. Clinical images: Castleman disease and paraneoplastic pemphigus. CMAJ 2010, 182:61.
122. Shi B.B., Li H.Z., Zhao L., et al. Paraneoplastic pemphigus caused by Castleman's disease masquerading as an adrenal neoplasm. J Clin Endocrinol Metab 2009, 94:1841-1842.
123. Wu X.Y., Song H.M., Shen J. Castleman disease with paraneoplastic pemphigus in a child. Zhonghua Er Ke Za Zhi 2008, 46:149-150.
124. Mimouni D., Anhalt G.J., Lazarova Z., et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002, 147:725-732.
125. Lane J.E., Woody C., Davis L.S., et al. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature. Pediatrics 2004, 114:e513-6.
126. Hung I.J., Lin J.J., Yang C.P., et al. Paraneoplastic syndrome and intrathoracic Castleman disease. Pediatr Blood Cancer 2006, 47:616-620.
127. Marzano A.V., Vezzoli P., Mariotti F., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castleman disease. Br J Dermatol 2005, 153:214-215.
128. Wang J., Zhu X., Li R., et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 2005, 141:1285-1293.
129. Wang J., Bu D.F., Li T., et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 2005, 153:558-564.
130. Barbetakis N., Samanidis G., Paliouras D., Chnaris A. eComment: Paraneoplastic skin diseases in thymoma patients. Interact Cardiovasc Thorac Surg 2009, 9:346.
131. Barbetakis N., Samanidis G., Paliouras D., et al. Paraneoplastic pemphigus regression after thymoma resection. World J Surg Oncol 2008, 6:8.
132. Winkler D.T., Strnad P., Meier M.L., et al. Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade. J Neurol 2007, 254:1601-1603.
133. Leyn J., Degreef H. Paraneoplastic pemphigus in a patient with a thymoma. Dermatology 2001, 202:151-154.
134. Lee S.E., Kim H.R., Hashimoto T., et al. Paraneoplastic pemphigus developed shortly after resection of follicular dendritic cell sarcoma. Acta Derm Venereol 2008, 88:410-412.
135. Meijs M., Mekkes J., van Noesel C., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. Int J Dermatol 2008, 47:632-634.
136. Krunic A.L., Kokai D., Bacetic B., et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol 1997, 36:526-529.
137. Berg W.A., Fishman E.K., Anhalt G.J. Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. South Med J 1993, 86:215-217.
138. Perera G.K., Devereux S., Mufti G., et al. PNP with Waldenström's macroglobulinaemia. Clin Exp Dermatol 2005, 30:27-29.
139. Cervini A.B., Tosi V., Kim S.H., et al. Paraneoplastic pemphigus or paraneoplastic autoimmune multiorgan syndrome. Report of 2 cases in children and a review of the literature. Actas Dermosifiliogr 2010, 101:879-886.
140. Sehgal V.N., Srivastava G. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol 2009, 48:162-169.
141. Kaplan I., Hodak E., Ackerman L., et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004, 40:553-562.
142. Matz H., Milner Y., Frusic-Zlotkin M., et al. Paraneoplastic pemphigus associated with pancreatic carcinoma. Acta Derm Venereol 1997, 77:289-291.
143. Niimi Y., Kawana S., Hashimoto T., et al. Paraneoplastic pemphigus associated with uterine carcinoma. J Am Acad Dermatol 2003, 48:S69-72.
144. Kennedy N.A., Dawe S. Atypical paraneoplastic pemphigus secondary to endometrial carcinoma with no mucosal involvement. Clin Exp Dermatol 2009, 34:30-33.
145. Hinterhuber G., Drach J., Riedl E., et al. Paraneoplastic pemphigus in association with hepatocellular carcinoma. J Am Acad Dermatol 2003, 49:538-540.
146. Yokokura H., Demitsu T., Kakurai M., et al. Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma. J Dermatol 2006, 33:842-845.
147. Aessopos A., Grapsa A., Farmakis D., et al. Oral paraneoplastic pemphigus associated with renal malignancy. Acta Derm Venereol 2003, 83:72-73.
148. Masu T., Okuyama R., Tsunoda T., et al. Paraneoplastic pemphigus associated with malignant gastrointestinal stromal tumour. Acta Derm Venereol 2010, 90:89-90.
149. Chorzelski T., Hashimoto T., Maciejewska B., et al. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 1999, 41:393-400.
150. Eccersley L.R., Hoffbrand A.V., Rustin M.H., et al. Paraneoplastic pemphigus associated with systemic mastocytosis. Am J Hematol 2009, 84:847-848.
151. Mascaró J.M., Ferrando J., Solé M.T., et al. Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis. Dermatology 1999, 199:63-66.
152. Mar W.A., Glaesser R., Struble K., et al. Paraneoplastic pemphigus with bronchiolitis obliterans in a child. Pediatr Dermatol 2003, 20:238-242.
153. Iranzo P., Xaubet A., Carrera C., et al. Bronchiolitis obliterans associated with paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome. Arch Bronconeumol 2004, 40:240-243.
154. Wang S.H., Chu C.Y., Chen H.H., et al. Paraneoplastic Pemphigus and Bronchiolitis Obliterans in a Patient with Splenic B-cell Lymphoma. J Formos Med Assoc 2007, 106:768-773.
155. Schaeppi H., Bauer J.W., Hametner R., et al. A localized variant of paraneoplastic pemphigus: acantholysis associated with malignant melanoma. Br J Dermatol 2001, 144:1249-1254.
156. Lyon C.C., Carmichael A.J. Toxic epidermal necrolysis and paraneoplastic pemphigus. Lancet 1998, 352:149.
157. Braess J., Reich K., Willert S., et al. Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL). Ann Hematol 1997, 75:227-230.
158. Gooptu C., Littlewood T.J., Frith P., et al. Paraneoplastic pemphigus: an association with fludarabine?. Br J Dermatol 2001, 144:1255-1261.
159. Yildiz O., Ozguroglu M., Yanmaz M.T., et al. Paraneoplastic pemphigus associated with fludarabine use. Med Oncol 2007, 24:115-118.
160. Bazarbachi A., Bachelez H., Dehen L., et al. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol 1995, 6730-6731.
161. Lee M.S., Kossard S., Ho K.K., et al. Paraneoplastic pemphigus triggered by radiotherapy. Australas J Dermatol 1995, 36:206-210.
162. Kirsner R.S., Anhalt G.J., Kerdel F.A. Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995, 132:474-478.
163. Kakurai M., Demitsu T., Iida E., et al. Coexistence of paraneoplastic pemphigus and bullous pemphigoid. J Eur Acad Dermatol Venereol 2009, 23:962-964.
164. Ishii N., Hashimoto T. A case of paraneoplastic pemphigus who shifted to pemphigus vulgaris. J Eur Acad Dermatol Venereol 2008, 22:374-375.
165. Scott DM, Davis D, Soderberg KI. Pemphigus, drug-induced. Emedicine. last updated Nov 13, 2009. Available at: Accessed: December 28, 2010. http://emedicine.medscape.com/article/1063684-overview.
166. Litt J.Z. Litt's drug eruption reference manual 2009, 715. Informa Healthcare, New York.
167. Sugita K., Hirokawa H., Izu K., et al. D-penicillamine-induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone. J Dermatolog Treat 2004, 15:214-217.
168. Szegedi A., Surányi P., Szücs G., et al. D-penicillamine-induced pemphigus vulgaris in a patient with scleroderma-rheumatoid arthritis overlap syndrome. Acta Derm Venereol 2004, 84:318-319.
169. Shapiro M., Jimenez S., Werth V.P. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol 2000, 42:297-299.
170. Peñas P.F., Buezo G.F., Carvajal I., et al. D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol 1997, 37:121-123.
171. Butt A., Burge S.M. Pemphigus vulgaris induced by captopril. Br J Dermatol 1995, 132:315-316.
172. Trinidad Paz J.M., Careaga Alzaga J.M., Pintos Neira J.M., et al. Captopril-induced pemphigus. Rev Clin Esp 1994, 194:999.
173. Arnoux D., Guiguen Y., Verdier M. Pemphigus induced by captopril. Ann Dermatol Venereol 1987, 114:1241-1242.
174. Hur J.W., Lee C.W., Yoo D.H. Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome. J Korean Med Sci 2006, 21:585-587.
175. Tholen S. Drug-induced pemphigus. Z Hautkr 1986, 61:719-723.
176. Civatte J. Drug-induced pemphigus diseases. Dermatol Monatsschr 1989, 175:1-7.
177. Patterson C.R., Davies M.G. Pemphigus foliaceus: an adverse reaction to lisinopril. J Dermatolog Treat 2004, 15:60-62.
178. Thind G.S. Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther 1990, 4:199-206.
179. Trotta F., Scaramelli M., Cervi G., et al. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis. Scand J Rheumatol 1984, 13:93-95.
180. Alinovi A., Benoldi D., Manganelli P. Pemphigus erythematosus induced by thiopronine. Acta DermVenereol 1982, 62:452-454.
181. de Angelis E., Lombardi M.L., Grassi M., et al. Enalapril: a powerful in vitro non-thiol acantholytic agent. Int J Dermatol 1992, 31:722-724.
182. Kuechle M.K., Hutton K.P., Muller S.A. Angiotensin-converting enzyme inhibitor induced pemphigus: three case reports and literature review. Mayo Clin Proc 1994, 69:1166-1171.
183. Vignes S., Paul C., Flageul B., et al. Ramipril-induced superficial pemphigus. Br J Dermatol 1996, 135:657-658.
184. Ong C.S., Cook N., Lee S. Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol 2000, 41:242-246.
185. Bae Y.I., Yun S.J., Lee S.C., et al. Pemphigus foliaceus induced by an angiotensin II receptor blocker. Clin Exp Dermatol 2008, 33:721-723.
186. Brenner S., Bialy-Golan A., Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998, 16:393-397.
187. Ghaffarpour G., Jalali M.H., Yaghmaii B., et al. Chloroquine/hydroxychloroquine induced pemphigus. Int J Dermatol 2006, 45:1261-1263.
188. Fleischmann M., Celerier P., Bernard P., et al. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology 1996, 192:50-55.
189. Cetkovska P., Pizinger K. Childhood pemphigus associated with montelukast administration. Clin Exp Dermatol 2003, 28:328-329.
190. Anadolu R.Y., Birol A., Bostanci S., et al. A case of pemphigus vulgaris possibly triggered by quinolones. J Eur Acad Dermatol Venereol 2002, 16:152-153.
191. Bauza A., Del Pozo L.J., Saus C., et al. Pemphigus-like lesions induced by imiquimod. Clin Exp Dermatol 2009, 34:e60-2.
192. Mashiah J., Brenner S. Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol 2005, 141:908-909.
193. Lin R., Ladd D.J., Powell D.J., et al. Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol 2004, 140:889-890.
194. Downie J.B., Dicostanzo D.P., Cohen S.R. Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse. J Am Acad Dermatol 1998, 39:872-875.
195. Tan S.R., McDermott M.R., Castillo C.J., et al. Pemphigus vulgaris induced by electrical injury. Cutis 2006, 77:161-165.
196. Hogan P. Pemphigus vulgaris following a cutaneous thermal burn. Int J Dermatol 1992, 31:46-49.
197. Langan S.M., Smeeth L., Hubbard R., et al. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008, a180:337.
198. Nemeth A.J., Klein A.D., Gould E.W., et al. Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 1991, 127:378-386.
199. Kirtschig G., Wojnarowska F., Marsden R.A., et al. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting. Br J Dermatol 1994, 130:610-616.
200. Amos B., Deng J.S., Flynn K., et al. Bullous pemphigoid in infancy: case report and literature review. Pediatr Dermatol 1998, 15:108-111.
201. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol 2002, 29:781-785.
202. Baykal C., Okan G., Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001, 44:348-350.
203. Venning V.A., Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 1990, 123:439-445.
204. Chorzelski T.P., Jablonska S., Maciejowska E., et al. Coexistence of malignancies with bullous pemphigoid. Arch Dermatol 1978, 114:964.
205. Bergler-Czop B., Lis-Swiçty A., Brzezińska-Wcisło L., et al. Bullous pemphigoid in the course of breast diseases: both breasts, neoplasmatic tumor; right breast, neoplasmatic tumor; and mastopathy-presentation of three cases in women aged 65 and older. J Am Geriatr Soc 2009, 57:754-756.
206. Gül U., Kiliç A., Demirel O., et al. Bullous pemphigoid associated with breast carcinoma. Eur J Dermatol 2006, 16:581-582.
207. Yamamoto T., Tanaka A., Furuse Y. Bullous pemphigoid with esophageal cancer. J Dermatol 1994, 21:283-284.
208. Muramatsu T., Iida T., Tada H., et al. Bullous pemphigoid associated with internal malignancies: identification of 180-kDa antigen by western immunoblotting. Br J Dermatol 1996, 135:782-784.
209. Cakmak O., Seçkin D., Ceken I., et al. Bullous pemphigoid associated with parotid carcinoma. Otolaryngol Head Neck Surg 2002, 127:354-356.
210. Yanagi T., Kato N., Yamane N., Osawa R. Bullous pemphigoid associated with dermatomyositis and coloncarcinoma. Clin Exp Dermatol 2007, 32:291-294.
211. Umekoji A., Tsuruta D., Inoue T., et al. Bullous pemphigoid as a dermadrome associated with spindle cell carcinoma of the gallbladder. J Dermatol 2010, 37:251-254.
212. Graham-Brown R.A. Bullous pemphigoid with figurate erythema associated with carcinoma of the bronchus. Br J Dermatol 1987, 117:385-388.
213. Takeuchi M., Okazaki A., Nakajima N., et al. A case of lung cancer with bullous pemphigoid. Gan No Rinsho 1986, 32:529-533.
214. Zingsheim M., Gartmann H. Bullous pemphigoid and relief erythema as a paraneoplastic skin reaction in bronchial carcinoma. Z Hautkr 1974, 49:215-218.
215. Aractingi S., Bachmeyer C., Prost C., et al. Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders. Medicine (Baltimore) 1999, 78:228-235.
216. Egan C.A., Florell S.R., Zone J.J. Localized bullous pemphigoid in a patient with B-cell lymphoma. South Med J 1999, 92:1220-1222.
217. Misery L., Cambazard F., Rimokh R., et al. Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells. Br J Dermatol 1999, 141:155-157.
218. Rub R., Avidor Y., Messer G., et al. Bullous pemphigoid as an initial presentation of renal oncocytoma. Dermatology 1999, 198:322-323.
219. Ogawa H., Sakuma M., Morioka S., et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 1995, 9:136-141.
220. Bloom D. Psoriasis with superimposed bullous eruption (pemphigus). Med J Rec 1929, 130:246-248.
221. Thomsen K., Schmidt H. PUVA-induced bullous pemphigoid. Br J Dermatol 1976, 95:568-569.
222. Robinson J.K., Baughman R.D., Provost T.T. Bullous pemphigoid induced by PUVA therapy. Br J Dermatol 1978, 99:709-712.
223. Abel E., Bennett A. Bullous pemphigoid. Arch Dermatol 1979, 115:988-989.
224. Hisler B.M., Blumenthal N.C., Aronson P.J., et al. Bullous pemphigoid in psoriatic lesions. J Am Acad Dermatol 1989, 20:683-684.
225. Koerber W.A., Price N.M., Watson W. Psoriasis and bullous pemphigoid. Arch Dermatol 1978, 114:1643-1646.
226. Stüttgen G., Kentsch V. Psoriasis and pemphigoid positive correlation. Acta Derm Venereol Stockh 1979, 87:99-101.
227. Klein G.F., Rauschmeier W., Hinter H. Bullöses Pemphigoid mit lichtinduzierter Exazerbation und generalisiertem Nikolski-Zeichen. Hautarzt 1983, 34:33-35.
228. Wollina U., Schlesier F., Schaarschmidt H., et al. Einfluss der Ditranoltherapie auf Membran-, Basalmembran- und Kernmarker in Psoriasisläsionen. Z Hautkr 1987, 62:313-318.
229. Muramatsu T., Yamashina Y., Shirai T., et al. UVB irradiation reduces the expression of pemphigoid antigens in organ-cultured normal human skin. Arch Dermatol Res 1994, 286:142-144.
230. Kao C.L., Krathen R.A., Wolf J.E., et al. Psoralen plus ultraviolet A-induced bullous pemphigoid. J Drugs Dermatol 2008, 7:695-696.
231. Arregui M.A., Soloeta R., González R., et al. Bullous pemphigoid related to PUVA therapy: two further cases. Actas Dermosifiliogr 2006, 97:444-447.
232. Washio H., Hara H., Suzuki H., et al. Bullous pemphigoid on psoriasis lesions after UVA radiation. Acta Derm Venereol 2005, 85:561-563.
233. Stüttgen G. The risk of photochemotherapy. Int J Dermatol 1982, 21:198-202.
234. Hönigsmann H., Fitzpatrick T.B., Path M.a., Wolff K. Oral photochemotherapy with psoralens and UVA (PUVA): principles and practice. Dermatology in general medicine 1993, 1728-1754. McGraw-Hill, New York. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff (Eds.).
235. Bork K. Psoriasis und bullöses pemphigoid. Hautarzt 1987, 38:348-351.
236. Grunwald M.H., David M., Feuerman E.J. Coexistence of psoriasis vulgaris and bullous diseases. Acad Dermatol 1985, 13:224-228.
237. Burns D.A., Sarkony I. Generalized morphea with bullous lesions and psoriasis. Br J Dermatol 1976, 95:33-34.
238. Smith W.D.F., Lewis Jones M.S., Stewart T.W., et al. Bullous pemphigoid occurring in psoriatic plaques in association with Hashimoto's thyroiditis. Clin Exp Dermatol 1991, 16:389-391.
239. Pašić A., Ljubojević S., Lipozenčić J., et al. Coexistence of psoriasis vulgaris, bullous pemphigoid and vitiligo: a case report. J Eur Acad Dermatol Venereol 2002, 16:426-427.
240. Ljubojević S., Pašić A., Lipozenčić J., et al. Coexistence of psoriasis vulgaris and bullous diseases-review of the literature and case reports. Acta Dermatovenerologica Croatica 2000, 8:151-159.
241. Stingl G., Holubar K. Coexistence of lichen planus and bullous pemphigoid. A immunopathological study. Br J Dermatol 1975, 93:313-320.
242. Saurat J.H., Guinepain M.T., Didierjean L., et al. Coexistence of lichen planus and bullous pemphigoid (animmunofluorescence study of a "lichenpemphigoides"). Ann Dermatol Venereol 1977, 104:368-374.
243. Hintner H., Tappeiner G., Hönigsmann H., et al. Lichen planus and bullous pemphigoid. Acta Derm Venereol Suppl (Stockh) 1979, 59:71-76.
244. Stanley J.R. Bullous pemphigoid. Fitzpatrick's dermatology in general medicine 2008, 475-480. McGraw Hill, New York. K. Wolff, L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Leffel (Eds.).
245. Kumar V., Binder W.L., Schotland E., et al. Coexistence of bullous pemphigoid and systemic lupus erythematosus. Arch Dermatol 1978, 114:1187-1190.
246. Miller J.F., Downham T.F., Chapel T.A. Coexistent bullous pemphigoid and systemic lupus erythematosus. Cutis 1978, 21:368-373.
247. Clayton C.A., Burnham T.K. Systemic lupus erythematosus and coexisting bullous pemphigoid: immunofluorescent investigations. J Am Acad Dermatol 1982, 7:236-245.
248. Stoll D.M., King L.E. Association of bullous pemphigoid with systemic lupus erythematosus. Arch Dermatol 1984, 120:362-366.
249. Sant S.M., O'Loughlin S., Murphy G.M. Bullous pemphigoid and rheumatoid arthritis: is there disease association?. Ir J Med Sci 1997, 166:106-107.
250. Hsu V.M., Krey P.R., Schwartz R.A. Bullous pemphigoid and rheumatoid arthritis. Cutis 1989, 43:30-32.
251. Salo O.P., Räsänen J.A. Pemphigoid and rheumatoid arthritis. A clinical and immunological study. Ann Clin Res 1972, 4:173-177.
252. Giannini J.M., Callen J.P., Gruber G.G. Bullous pemphigoid and rheumatoid arthritis. J Am Acad Dermatol 1981, 4:695-697.
253. Patel RS, Harman KE, Nichols C, Burd RM, Pavord S. Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo. Postgrad Med J 2006;82:e3. Available at: Accessed: December 31, 2010. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563721/?tool=pubmed.
254. Lynfield Y.L., Green K., Gopal R. Bullous pemphigoid and multiple autoimmune diseases. Alopecia universalis, bullous pemphigoid, hypothyroidism, rheumatoid arthritis, and neutropenia in one patient. J Am Acad Dermatol 1983, 9:257-261.
255. Marcet B., Sibaud V., Géniaux M., et al. Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?. Ann Med Interne (Paris) 2002, 153:349-350.
256. Tirado-Sánchez A., Montes-de-Oca G. Coexistence of bullous pemphigoid, vitiligo, and thyroid disease: a multiple autoimmune syndrome?. Dermatol Online J 2005, 11:20.
257. Callen J.P., McCall M.W. Bullous pemphigoid and Hashimoto's thyroiditis. J Am Acad Dermatol 1981, 5:558-560.
258. Fiorucci M.C., Cozzani E., Casu M., et al. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol 2005, 85:560-561.
259. Glover M., Leigh I. Dermatomyositis pemphigoides: a case with coexistent dermatomyositis and bullous pemphigoid. J Am Acad Dermatol 1992, 27:849-852.
260. Peck S.M., Lefkovits A.M. Bullous pemphigoid with polymyositis and co-existing contact dermatitis. Arch Dermatol 1966, 94:672-674.
261. Taylor G., Venning V., Wojnarowska F. Bullous pemphigoid and associated autoimmune thrombocytopenia: two case reports. J Am Acad Dermatol 1993, 29:900-902.
262. van Joost T., Muntendam J., Heule F., et al. Subepidermal bullous autoimmune disease associated with immune nephritis. Immunomorphologic studies. J Am Acad Dermatol 1986, 14:214-220.
263. James W.D. Bullous pemphigoid, myasthenia gravis, and thymoma. Arch Dermatol 1984, 120:397.
264. Demathé A., Arede L.T., Miyahara G.I. Mucous membrane pemphigoid in HIV patient: a case report. Cases J 2008, 22:345.
265. De D., Kanwar A.J., Radotra B.D., et al. Bullous eruption in a patient infected with the human immunodeficiency virus. Skinmed 2008, 7:98-110.
266. Kinloch-de Loës S., Didierjean L., Rieckhoff-Cantoni L., et al. Bullous pemphigoid autoantibodies, HIV-1 infection and pruritic papular eruption. AIDS 1991, 5:451-454.
267. Taylor G., Venning V., Wojnarowska F., et al. Bullous pemphigoid and autoimmunity. J Am Acad Dermatol 1993, 29:181-184.
268. Jedlickova H., Hlubinka M., Pavlik T., Semradova V., Budinska E., Vlasin Z. Bullous pemphigoid and internal diseases-a case-control study. Eur J Dermatol 2010, 20:96-101.
269. Rosina P., Chieregato C., D'Onghia F.S. Bullous pemphigoid and diabetes mellitus. Acta Derm Venereol 1996, 76:497-498.
270. Chuang T.Y., Korkij W., Soltani K., et al. Increased frequency of diabetes mellitus in patients with bullous pemphigoid: a case-control study. J Am Acad Dermatol 1984, 11:1099-1102.
271. Callen J.P., Anderson T.F., Chanda J.J., et al. Bullous pemphigoid and other disorders associated with autoimmune phenomena. Arch Dermatol 1978, 114:245-246.
272. Obasi O.E., Savin J.A. Pemphigoid and pernicious anaemia. Br Med J 1977, 2:1458-1459.
273. Selby L., De Castro F., De Villiers W.J. The association of bullous pemphigoid and ulcerative colitis. Dig Dis Sci 2004, 49:1768-1770.
274. Harrison P.V., Blewitt R.W., Allen J., et al. Bullous pemphigoid and ulcerative colitis: a report of two cases and description of immunoblot findings. Br J Dermatol 1996, 134:599-600.
275. Kaplan R.P. Bullous pemphigoid and ulcerative colitis. Arch Dermatol 1991, 127:1728-1729.
276. Barth J.H., Kelly S.E., Wojnarowska F., et al. Pemphigoid and ulcerative colitis. J Am Acad Dermatol 1988, 19:303-308.
277. Ahmed A.R., Kaplan R.P., Hardy D., et al. Bullous pemphigoid and ulcerative colitis. Int J Dermatol 1982, 21:594-598.
278. How J., Bewsher P.D., Stankler L. Bullous pemphigoid, polymyalgia rheumatica and thyroid disease. Br J Dermatol 1980, 103:201-204.
279. Patterson J.W., Ali M., Murray J.C., et al. Bullous pemphigoid. Occurrence in a patient with mycosis fungoides receiving PUVA and topical nitrogen mustard therapy. Int J Dermatol 1985, 24:173-176.
280. Singhal P.C., Scharschmidt L.A. Membranous nephropathy associated with primary biliary cirrhosis and bullous pemphigoid. Ann Allergy 1985, 55:484-485.
281. Hamilton D.V., McKenzie A.W. Bullous pemphigoid and primary biliary cirrhosis. Br J Dermatol 1978, 99:447-450.
282. Bhat L., Sams H.H., King L.E. Bullous pemphigoid associated with Castleman disease. Arch Dermatol 2001, 137:965-966.
283. Halpern S.M., Parslew R., Cerio R., et al. Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid. Br J Dermatol 1997, 137:140-143.
284. Ross E.A., Ahmed A.R. Bullous pemphigoid-associated nephropathy: report of two cases and review of the literature. Am J Kidney Dis 1989, 14:225-229.
285. Soine E.J., Nelson P.S., Nesbitt L.T. A patient with coexistent bullous pemphigoid and primary membranous glomerulonephropathy. J Am Acad Dermatol 2009, 60:1042-1044.
286. Kawakami T., Fujita A., Shirai S., et al. Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy. J Am Acad Dermatol 2009, 60:523-524.
287. Nishioka N., Nasu K., Hoshizaki H., et al. Bullous pemphigoid associated with IgA nephropathy: a case report. Nippon Naika Gakkai Zasshi 1989, 78:925-929.
288. Simon C.A., Winkelmann R.K. Bullous pemphigoid and glomerulonephritis. Report of four cases. J Am Acad Dermatol 1986, 14:456-463.
289. Mérot Y., Poffet D., Glasson P., Chatelanat F., Saurat J.H. Glomerulonephritis and bullous pemphigoid: 2 cases. Ann Dermatol Venereol 1983, 110:739-740.
290. Barnadas M.A., Gelpí C., Rocamora V., et al. Bullous pemphigoid associated with acute glomerulonephritis. Br J Dermatol 1998, 138:867-871.
291. Bernstein J.E., Medenica M., Soltani K. Coexistence of localized bullous pemphigoid, morphea, and subcorneal pustulosis. Arch Dermatol 1981, 117:725-727.
292. Caudron A., Chatelain D., Christophe O., et al. Favourable progression of acquired hemophilia-associated bullous pemphigoid. Eur J Dermatol 2009, 19:383-384.
293. Soria A., Matichard E., Descamps V., et al. Bullous pemphigoid and acquired hemophilia. Ann Dermatol Venereol 2007, 134:353-356.
294. Akin M.A., Gunes T., Akýn L., et al. A newborn with bullous pemphigoid associated with linear IgA bullous dermatosis. Acta Dermatovenerol Alp Panonica Adriat 2009, 18:66-70.
295. Darling T.N., Cardenas A.A., Beard J.S., et al. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens. Arch Dermatol 1995, 131:1438-1442.
296. Setterfield J., Bhogal B., Black M.M., McGibbon D.H. Dermatitis herpetiformis and bullous pemphigoid: a developing association confirmed by immunoelectronmicroscopy. Br J Dermatol 1997, 136:253-256.
297. Falk E.S., Rekvig O.P. Mixed form of dermatitis herpetiformis and bullous pemphigoid. Acta Derm Venereol 1980, 60:229-234.
298. Langan S.M., Groves R.W., West J. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 2011, 131:631-636.
299. Stinco G., Codutti R., Scarbolo M., et al. A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. Acta Derm Venereol 2005, 85:136-139.
300. Masouyé I., Schmied E., Didierjean L., et al. Bullous pemphigoid and multiple sclerosis: more than a coincidence? Report of three cases. J Am Acad Dermatol 1989, 21:63-68.
301. Langer-Gould A., Albers K.B., Van Den Eeden S.K., et al. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 2010, 16:855-861.
302. Peramiquel L., Barnadas M.A., Pimentel C.L., et al. Bullous pemphigoid and multiple sclerosis: a report of two cases with ELISA test. Eur J Dermatol 2007, 17:62-66.
303. Kirtschig G., Walkden V.M., Venning V.A., et al. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995, 20:449-453.
304. Trozak D.J. Bullous pemphigoid and multiple sclerosis. J Am Acad Dermatol 1990, 22:860.
305. Gebauer K., Cox J., Gartside J., et al. Bullous pemphigoid and multiple sclerosis. J Am Acad Dermatol 1990, 23:329.
306. Forschner A., Ulmer A., Rassner G., et al. Bullous pemphigoid in a patient with Parkinson's disease. Eur J Dermatol 2002, 12:615.
307. Chosidow O., Doppler V., Bensimon G., et al. Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?. Arch Dermatol 2000, 136:521-524.
308. García-Estévez D.A., Peón-Currás G., Bal-Nieves F. Bullous pemphigoid and amyotrophic lateral sclerosis. Rev Neurol 2008, 47:525-526.
309. Taghipour K., Chi C.C., Vincent A., et al. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 2010, 146:1251-1254.
310. Okazaki A., Iida T., Muramatsu T., et al. Bullous pemphigoid associated with Shy-Drager syndrome. J Dermatol 1998, 25:465-468.
311. Leung C.L., Zheng M., Prater S.M., et al. The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 2001, 20:691-697.
312. Macfarlane A.W., Verbov J.L. Trauma-induced bullous pemphigoid. Clin Exp Dermatol 1989, 14:245-249.
313. Xu H.H., Xiao T., He C.D., et al. Bullous pemphigoid triggered by a boiling water burn. Eur J Dermatol 2008, 18:466-467.
314. Blaise G., Piérard-Franchimont C., Quatresooz P., et al. Post-thermal burn bullous pemphigoid. Rev Med Liege 2008, 63:182-183.
315. Vermeulen C., Janier M., Panse I., et al. Localized bullous pemphigoid induced by thermal burn. Ann Dermatol Venereol 2000, 127:720-722.
316. Chen D.M., Fairley J.A. A bullous pemphigoid-like skin eruption after a chemical burn. J Am Acad Dermatol 1998, 38:337-340.
317. Vassileva S., Mateev G., Tsankov N. Burn-induced bullous pemphigoid. Int J Dermatol 1995, 34:516-517.
318. Cabrera-Rodríguez J.J., Muñoz-García J.L., Rivero Quirós, et al. Radio-induced bullous pemphigoid. Clin Transl Oncol 2010, 12:66-68.
319. Folliero G., Zurlo A., Amanti C., et al. Bullous pemphigoid induced by radiation therapy. Clin Oncol (R Coll Radiol) 1995, 7:266-267.
320. Sheerin N., Bourke J.F., Holder J., North J., Burns D.A. Bullous pemphigoid following radiotherapy. Clin Exp Dermatol 1995, 20:80-82.
321. Duschet P., Schwarz T., Gschnait F. Bullous pemphigoid after radiation therapy. J Am Acad Dermatol 1988, 18:441-444.
322. Bastuji-Garin S., Joly P., Picard-Dahan C., et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996, 132:272-276.
323. Ruocco V., Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991, 30:307-312.
324. Fellner M.J. Drug-induced bullous pemphigoid. Clin Dermatol 1993, 11:515-520.
325. Butler D.F. Drug-induced bullous disorders. Emedicine Last updated Jan 6, 2009. Available at:, Accessed: December 31, 2010. http://emedicine.medscape.com/article/1062790-overview.
326. Lee J.J., Downham T.F. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006, 5:562-564.
327. Baz K., Ikizoglu G., Kaya T.I., et al. Furosemide-induced bullous pemphigoid. J Eur Acad Dermatol Venereol 2002, 16:81-82.
328. Panayiotou B.N., Prasad M.V., Zaman M.N. Frusemide-induced bullous pemphigoid. Br J Clin Pract 1997, 51:49-50.
329. Koch C.A., Mazzaferri E.L., Larry J.A., et al. Bullous pemphigoid after treatment with furosemide. Cutis 1996, 58:340-344.
330. Modeste A.B., Cordel N., Courville P., et al. Bullous pemphigoid induced by spironolactone. Ann Dermatol Venereol 2002, 129:56-58.
331. Perry A., Sparling J.D., Pennington M. Bullous pemphigoid following therapy with an oral beta-blocker. J Drugs Dermatol 2005, 4:746-748.
332. Stoebner P.E., Michot C., Ligeron C., et al. Simvastatin-induced lichen planus pemphigoides. Ann Dermatol Venereol 2003, 130:187-190.
333. Mallet L., Cooper J.W., Thomas J. Bullous pemphigoid associated with captopril. DICP 1989, 23:6.
334. Pompeová L. Bullous pemphigoid induced by taking Brufen (author's transl). Cesk Dermatol 1981, 56:256-258.
335. Popadic S., Skiljevic D., Medenica L. Bullous pemphigoid induced by penicillamine in a patient with Wilson disease. Am J Clin Dermatol 2009, 10:36-38.
336. Chi C.C., Wang S.H., Charles-Holmes R., et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 2009, 160:1222-1228.
337. Shornick J.K. Pemphigoid gestationis (herpes gestationis). Fitzpatrick's dermatology in general medicine 2008, 490-493. McGraw Hill Medical, New York. K. Wolff, L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Jeffell (Eds.).
338. Holmes R.C., Black M.M., Jurecka W., et al. Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol 1983, 109:131-139.
339. Shornick J.K., Black M.M. Secondary autoimmune diseases in herpes gestationis (pemphigoid gestationis). J Am Acad Dermatol 1992, 26:563-566.
340. Holmes R.C., Black M.M. Herpes gestationis. A possible association with autoimmune thyrotoxicosis (Graves' disease). J Am Acad Dermatol 1980, 3:474-477.
341. Shornick J.K., Stastny P., Gilliam J.N. High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest 1981, 68:553-555.
342. Messer G., Schirren H., Meurer M. Herpes gestationis: immunologic and immunogenetic aspects. Hautarzt 1993, 44:761-766.
343. Gammon W.R., Heise E.R., Burke W.A., et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988, 91:228-232.
344. Gammon W.R., Briggaman R.A. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993, 11:535-547.
345. McHenry P.M., Dagg J.H., Tidman M.J., et al. Epidermolysis bullosa acquisita occurring in association with systemic lupus erythematosus. Clin Exp Dermatol 1993, 18:378-380.
346. Dotson A.D., Raimer S.S., Pursley T.V., et al. Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita. Arch Dermatol 1981, 117:422-426.
347. Hughes B.R., Horne J. Epidermolysis bullosa acquisita and total ulcerative colitis. J R Soc Med 1988, 81:473-475.
348. Chan L.S., Woodley D.T. Pemphigoid: bullous and cicatricial. Current therapy in allergy, immunology and rheumatology 1996, 93. Mosby, St Louis. L.M. Lichtenstein, A.S. Fauci (Eds.).
349. Hundorfean G., Neurath M.F., Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010, 14:2393-2403.
350. Vicente E.F., Hernández-Núñez A., Aspa J., et al. Crohn's disease, relapsing polychondritis and epidermolysis bullosa acquisita: an immune-mediated inflammatory syndrome. Rheumatology (Oxford) 2008, 47:380-381.
351. Raab B., Fretzin D.F., Bronson D.M., et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. JAMA 1983, 250:1746-1748.
352. Al-Ratrout J.T., Ansari N.A. Epidermolysis bullosa acquisita and Crohn's disease. Saudi Med J 2004, 25:1736-1738.
353. Labeille B., Gineston J.L., Denoeux J.P., et al. Epidermolysis bullosa acquisita and Crohn's disease. A case report with immunological and electron microscopic studies. Arch Intern Med 1988, 148:1457-1459.
354. Chen M., O'Toole E.A., Sanghavi J., et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002, 118:1059-1064.
355. Chen M., Marinkovich M.P., Veis A., et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components: a potential role in epidermal-dermal adherence in human skin. J Biol Chem 1997, 272:14516-14522.
356. Soria C., Muñoz E., España A., et al. Acquired bullous epidermolysis and multiple myeloma. Med Cutan Ibero Lat Am 1990, 18:206-211.
357. Engineer L., Dow E.C., Braverman I.M., et al. Epidermolysis bullosa acquisita and multiple myeloma. J Am Acad Dermatol 2002, 47:943-946.
358. Radfar L., Fatahzadeh M., Shahamat Y., et al. Paraneoplastic epidermolysis bullosa acquisita associated with multiple myeloma. Spec Care Dentist 2006, 26:159-163.
359. Kanoh T., Tanaka S. Epidermolysis bullosa acquisita in multiple myeloma associated with skin amyloidosis (author's transl). Nippon Naika Gakkai Zasshi 1978, 67:600-605.
360. Trump D.L., Allen H., Olson J., et al. Epidermolysis bullosa acquisita. Association with amyloidosis and multiple myeloma. JAMA 1980, 243:1461-1462.
361. Endo Y., Tamura A., Ishikawa O., et al. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. Br J Dermatol 1997, 137:783-786.
362. Hoshina D., Sawamura D., Nomura T., et al. Epidermolysis bullosa acquisita associated with psoriasis vulgaris. Clin Exp Dermatol 2007, 32:516-518.
363. Shaw M., McKee P.H., Gaminara E., et al. Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia. Clin Exp Dermatol 1985, 10:162-168.
364. Morita E., Horiuchi K., Yamamoto S., et al. A case of acquired autoimmune bullous disease associated with IgM macroglobulinaemia. J Dermatol 1999, 26:671-676.
365. Burke W.A., Briggaman R.A., Gammon W.R. Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol 1986, 122:187-189.
366. Busch J.O., Sticherling M. Epidermolysis bullosa acquisita and neuroendocrine pancreatic cancer-Coincidence or patho-genetic relationship?. J Dtsch Dermatol Ges 2007, 5:916-918.
367. Chamberlain A.J., Cooper S.M., Allen J., et al. Paraneoplastic immunobullous disease with an epidermolysis bullosa acquisita phenotype: two cases demonstrating remission with treatment of gynaecological malignancy. Australas J Dermatol 2004, 45:136-139.
368. Etienne A., Ruffieux P., Didierjean L., et al. Epidermolysis bullosa acquisita and metastatic cancer of the uterine cervix. Ann Dermatol Venereol 1998, 125:321-323.
369. Bernard P., Bedane C., Taieb A., et al. Squamous cell carcinoma complicating acquired bullous epidermolysis. Ann Dermatol Venereol 1992, 119:35-36.
370. Klein J.S., Goldin H.M., Keegan C., et al. Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1991, 24:297.
371. Osawa M., Demitsu T., Toda S., et al. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis. Dermatology 2005, 211:146-148.
372. Delbaldo C., Chen M., Friedli A., et al. Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen. J Am Acad Dermatol 2002, 46:S161-S164.
373. Egan C.A., O'Loughlin S., Gormally S., et al. Dermatitis herpetiformis: a review of fifty-four patients. Ir J Med Sci 1997, 166:241-244.
374. Fry L., Keir P., McMinn R.M.H., et al. AV Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet 1967, 2:729-734.
375. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999, 117:297-303.
376. Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996, 38:528-530.
377. Reunala T., Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997, 136:315-318.
378. Kaplan R.P., Callen J.P. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol 1991, 9:347-360.
379. Halliwell R.E. Skin diseases associated with autoimmunity. Vet Clin North Am Small Anim Pract 1979, 9:57-71.
380. Zettinig G., Weissel M., Flores J., et al. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest 2000, 30:53-57.
381. Reijonen H., Ilonen J., Knip M., et al. Insulin-dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes. Tissue Antigens 1991, 37:94-96.
382. Kurano T.L., Lum C.A., Izumi A.K. The association of dermatitis herpetiformis and systemic lupus erythematosus. J Am Acad Dermatol 2010, 63:892-895.
383. Aronson A.J., Soltani K., Aronson I.K., et al. Systemic lupus erythematosus and dermatitis herpetiformis: concurrence with Marfan's syndrome. Arch Dermatol 1979, 115:68-70.
384. Fraser N.G., Rennie A.G., Donald D. Dermatitis herpetiformis and Sjögren's syndrome. Br J Dermatol 1979, 100:213-215.
385. White S.W., Tesar J.T. Dermatomyositis and dermatitis herpetiformis. Arch Dermatol 1982, 118:599-601.
386. Kalovidouris A.E., Miller F.W., Lawley T.J. Polymyositis/dermatomyositis associated with dermatitis herpetiformis. Arthritis Rheum 1989, 32:1179-1181.
387. Olholm-Larsen P., Kavli G. Dermatitis herpetiformis and vitiligo. Dermatologica 1980, 160:41-44.
388. Amato L., Gallerani I., Fuligni A., et al. Dermatitis herpetiformis and vitiligo: report of a case and review of the literature. J Dermatol 2000, 27:462-466.
389. Hogan D.J., Lane P.R. Dermatitis herpetiformis and vitiligo. Cutis 1986, 38:195-197.
390. Aydog E., Yesilli O., Sever A., et al. Dermatitis herpetiformis and rheumatoid arthritis. Saudi Med J 2006, 27:881-884.
391. Viljamaa M., Kaukinen K., Pukkala E., et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006, 38:374-380.
392. Hervonen K., Vornanen M., Kautiainen H., et al. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 2005, 152:82-86.
393. Bose S.K., Lacour J.P., Bodokh I., et al. Malignant lymphoma and dermatitis herpetiformis. Dermatology 1994, 188:177-181.
394. Lancaster-Smith M.J., Kumar P.J., et al. Letter: atrophic gastritis and dermatitis herpetiformis. Lancet 1974, 2:777.
395. O'Donoghue D.P., Lancaster-Smith M., Johnson G.D., et al. Gastric lesion in dermatitis herpetiformis. Gut 1976, 17:185-188.
396. Lambert D., Collet E., Foucher J.L., et al. Dermatitis herpetiformis associated with ulcerative colitis. Clin Exp Dermatol 1991, 16:458-459.
397. Wills A.J., Turner B., Lock R.J., et al. Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry 2002, 72:259-261.
398. Daneshmend T.K., Gardner-Thorpe C. Cerebellar ataxia and sensory neuropathy associated with dermatitis herpetiformis. Br J Dermatol 1981, 104:593-595.
399. Zertsalova G.N., Kochetkov V.D. Dermato-neurological changes in patients with Duhring's dermatitis. Vestn Dermatol Venerol 1974, 0:31-35.
400. Callen J.P., Weston W.F., Chanda J.J. Dermatitis herpetiformis and thyrotoxicosis. Int J Dermatol 1979, 18:219-221.
401. Isaac M., McNeely M.C. Dermatitis herpetiformis associated with lichen planopilaris. J Am Acad Dermatol 1995, 33:1050-1051.
402. Laurent R., Humbert P., Fellman D. Dermatitis herpetiformis associated with relapsing polychondritis. Dermatologica 1988, 177:309-312.
403. Grenier R., Rostas A., Wilkinson R.D. Dermatitis herpetiformis and leiomyomas with HLA-B8, a marker of immune diseases. Can Med Assoc J 1976, 115:882-884.
404. Gabrielsen T.O., Hoel P.S. Primary biliary cirrhosis associated with coeliac disease and dermatitis herpetiformis. Dermatologica 1985, 170:31-34.
405. Reunala T., Salmi J., Karvonen J. Dermatitis herpetiformis and celiac disease associated with Addison's disease. Arch Dermatol 1987, 123:930-932.
406. Gaboardi F, Perletti L., Cambié M., et al. Dermatitis herpetiformis and nephrotic syndrome. Clin Nephrol 1983, 20:49-51.
407. Helin H., Mustonen J., Reunala T., et al. IgA nephropathy associated with celiac disease and dermatitis herpetiformis. Arch Pathol Lab Med 1983, 107:324-327.
408. Joly P., Soubrane J.C., Thomine E., et al. Dermatitis herpetiformis and hemodialysis. Dermatologica 1987, 175:249-252.
409. Klein P.A., Callen J.P. Linear IgA dermatosis Updated: Sep 28, 2010. Emedicine. Available at:, Accessed: December 31, 2010. http://emedicine.medscape.com/article/1063590-overview.
410. Tobón G.J., Toro C.E., Bravo J.C., et al. Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report. Clin Rheumatol 2008, 27:391-393.
411. Barrows-Wade L., Jordon R.E., Arnett F.C. Linear IgA bullous dermatosis associated with dermatomyositis. Arch Dermatol 1992, 128:413-414.
412. Hayakawa K., Shiohara T., Yagita A., et al. Linear IgA bullous dermatosis associated with rheumatoid arthritis. J Am Acad Dermatol 1992, 26:110-113.
413. Takagi Y., Sawada S., Yamauchi M., et al. Coexistence of psoriasis and linear IgA bullous dermatosis. Br J Dermatol 2000, 142:513-516.
414. Godfrey K., Wojnarowska F., Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1990, 123:447-452.
415. Yhim H.Y., Kwon D.H., Lee N.R., Song E.K., Yim C.Y., Kwak J.Y. Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma. Bone Marrow Transplant 2011, 46:156-158.
416. Gantzer A., Bouaziz J.D., Valeyrie-Allanore L., et al. Acute linear IgA bullous dermatosis with circulating IgA monoclonal antibody associated with Hodgkin's disease. Ann Dermatol Venereol 2010, 137:819-820.
417. Usmani N., Baxter K.F., Child J.A., et al. Linear IgA disease in association with chronic lymphocytic leukaemia. Br J Dermatol 2004, 151:710-711.
418. Lai-Cheong J.E., Groves R.W., Banerjee P. Linear IgA bullous dermatosis associated with adenocarcinoma of the ascending colon. J Eur Acad Dermatol Venereol 2007, 21:978-979.
419. Holló P., Preisz K., Nemes L., et al. Linear IgA dermatosis associated with chronic clonal myeloproliferative disease. Int J Dermatol 2003, 42:143-146.
420. Sekula S.A., Tschen J.A., Bean S.F., Wolf J.E. Linear IgA bullous disease in a patient with transitional cell carcinoma of the bladder. Cutis 1986, 38:354-356. 362.
421. van der Waal R.I., van de Scheur M.R., Pas H.H., et al. Linear IgA bullous dermatosis in a patient with renal cell carcinoma. Br J Dermatol 2001, 144:870-873.
422. Lacour J.P., Vitetta A., Ortonne J.P. Linear IgA dermatosis and thyroid carcinoma. J Am Acad Dermatol 1992, 26:257-259.
423. Adamic M., Potocnik M., Pavlovic M.D. Linear IgA bullous dermatosis in a patient with advanced pancreatic carcinoma. Clin Exp Dermatol 2008, 33:503-505.
424. Green S.T., Natarajan S. Linear IgA disease and oesophageal carcinoma. J R Soc Med 1987, 80:48-49.
425. McEvoy M.T., Connolly S.M. Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol 1990, 22:59-63.
426. Wong D.A., Hunt M.J., Stapleton K. IgA multiple myeloma presenting as an acquired bullous disorder. Australas J Dermatol 1999, 40:31-34.
427. Oranje A.P., Vuzevski V.D., Bouquet J., et al. Linear IgA disease and chronic active hepatitis-a coincidence or not?. Acta Derm Venereol 1985, 65:440-442.
428. Barberis C., Doutre M.S., Bioulac-Sage P., et al. Linear IgA bullous dermatosis associated with Crohn's disease. Gastroenterol Clin Biol 1988, 12:76-77.
429. Klein A., Wenzel S.M., Messmer E.M., et al. Linear IgA disease with ocular involvement associated with ulcerative colitis. Hautarzt 2010, 61:55-57.
430. De Simone C., Guerriero C., Pellicano R. Linear IgA disease and ulcerative colitis. Eur J Dermatol 1998, 8:48-50.
431. Kapur A., Isaacs P.E., Kelsey P.R. Linear IgA dermatosis, coeliac disease, and extraintestinal B cell lymphoma. Gut 1995, 37:731-733.
432. Abreu A., Bowers K., Mattson D.H., et al. Linear IgA bullous dermatosis in association with multiple sclerosis. J Am Acad Dermatol 1994, 31:797-799.
433. Arakaki O., Yamamoto Y., Awazawa R., et al. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia. J Dermatol 2008, 35:437-446.
434. Pena-Penabad C., Hernández-Vicente I., Hernández-Martín A., et al. IgA mesangial nephropathy and autoimmune haemolytic anaemia associated with linear IgA bullous dermatosis. Br J Dermatol 1995, 133:146-148.
435. Aboumaria A., Benarafa A., Senouci K., et al. Linear IgA bullous dermatosis associated with spondylarthropathy in a child. Ann Dermatol Venereol 2008, 135:313-315.
436. Egan C.L., Liu V., Harris R.M., et al. Linear IgA disease associated with membranous glomerulonephropathy. Int J Dermatol 2000, 39:379-382.
437. Gamo R., Aguilar A., Gónzalez-Valle O., et al. Localized linear IgA disease associated with monoclonal gammapathy of undetermined significance. J Eur Acad Dermatol Venereol 2007, 21:544-545.
438. Kelly S.E., Wojnarowska F., Darley C. Linear IgA disease in association with hydatidiform mole. J R Soc Med 1989, 82:438-439.
439. Porter W.M., Hardman C.M., Leonard J.N., et al. Sarcoidosis in a patient with linear IgA disease. Clin Exp Dermatol 1999, 2467-2470.
440. Ahkami R., Thomas I. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection. Cutis 2001, 67:423-426.
441. Blickenstaff R.D., Perry H.O., Peters M.S. Linear IgA deposition associated with cutaneous varicella-zoster infection: a case report. J Cutan Pathol 1988, 15:49-52.
442. Girao L., Fiadeiro T., Rodrigues J.C. Burn-induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000, 14:507-510.
443. Nousari H.C., Kimyai-Asadi A., Caeiro J.P., et al. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999, 78:1-8.
444. Kocyigit P., Akay B.N., Karaosmanoglu N. Linear IgA bullous dermatosis induced by interferon-alpha 2a. Clin Exp Dermatol 2009, 34:e123-4.
445. Khan I., Hughes R., Curran S., et al. Drug-associated linear IgA disease mimicking toxic epidermal necrolysis. Clin Exp Dermatol 2009, 34:715-717.
446. Santos-Juanes J., Coto Hernández R., Trapiella L., et al. Amoxicillin-associated linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol 2007, 21:992-993.
447. Bouldin M.B., Clowers-Webb H.E., Davis J.L., et al. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clin Proc 2000, 75:967-970.
448. Cerottini J.P., Ricci C., Guggisberg D., et al. Drug-induced linear IgA bullous dermatosis probably induced by furosemide. J Am Acad Dermatol 1999, 41:103-105.
449. Alberta-Wszolek L., Mousette A.M., Mahalingam M., et al. Linear IgA bullous dermatosis following influenza vaccination. Dermatol Online J 2009, 15:3.
450. Humbert P., Dupond J.L. Multiple autoimmune syndromes. Ann Med Interne 1988, 139:159-168.
451. Humbert P., Dupond J.L. Multiple autoimmune syndromes (MAS). Br J Dermatol 1997, 136:468-469.
452. Moore E. Multiple autoimmune syndrome. Suite 101.com Available at:, Accessed: December 20, 2010. http://www.suite101.com/content/multiple-autoimmune-syndrome-a18505.